KLI

Prostaglandin E 2 receptor PTGER4-expressing macrophages promote intestinal epithelial barrier regeneration upon inflammation

Metadata Downloads
Abstract
Objective: Dysfunctional resolution of intestinal inflammation and altered mucosal healing are essential features in the pathogenesis of inflammatory bowel disease (IBD). Intestinal macrophages are vital in the process of inflammation resolution, but the mechanisms underlying their mucosal healing capacity remain elusive.

Design: We investigated the role of the prostaglandin E2 (PGE2) receptor PTGER4 on the differentiation of intestinal macrophages in patients with IBD and mouse models of intestinal inflammation. We studied mucosal healing and intestinal epithelial barrier regeneration in Csf1r-iCre Ptger4fl/fl mice during dextran sulfate sodium (DSS)-induced colitis. The effect of PTGER4+ macrophage secreted molecules was investigated on epithelial organoid differentiation.

Results: Here, we describe a subset of PTGER4-expressing intestinal macrophages with mucosal healing properties both in humans and mice. Csf1r-iCre Ptger4fl/fl mice showed defective mucosal healing and epithelial barrier regeneration in a model of DSS colitis. Mechanistically, an increased mucosal level of PGE2 triggers chemokine (C-X-C motif) ligand 1 (CXCL1) secretion in monocyte-derived PTGER4+ macrophages via mitogen-activated protein kinases (MAPKs). CXCL1 drives epithelial cell differentiation and proliferation from regenerating crypts during colitis. Specific therapeutic targeting of macrophages with liposomes loaded with an MAPK agonist augmented the production of CXCL1 in vivo in conditional macrophage PTGER4-deficient mice, restoring their defective epithelial regeneration and favouring mucosal healing.

Conclusion: PTGER4+ intestinal macrophages are essential for supporting the intestinal stem cell niche and regeneration of the injured epithelium. Our results pave the way for the development of a new class of therapeutic targets to promote macrophage healing functions and favour remission in patients with IBD.
Author(s)
이호수Boyoun ParkDaesik KimDaun JungGianluca MatteoliGyo Jeong GuHak Jae KimHeonjong HanHyeri JangIsabelle CleynenJi Yong ParkJong Pil ImKyu Joo ParkMi Reu JeongMichelle StakenborgSeung Bum RyooSeung Hyeok SeokSoo Youn SuhSungwook LeeTae Sik SungYi Rang NaYoon Hey KwonYun Sang
Issued Date
2021
Type
Article
Keyword
epithelial barrierepithelial differentiationinflammatory bowel diseasemacrophagesprostaglandins
DOI
10.1136/gutjnl-2020-322146
URI
https://oak.ulsan.ac.kr/handle/2021.oak/8281
https://ulsan-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=TN_cdi_pubmed_primary_33558271&context=PC&vid=ULSAN&lang=ko_KR&search_scope=default_scope&adaptor=primo_central_multiple_fe&tab=default_tab&query=any,contains,Prostaglandin%20E%202%20receptor%20PTGER4-expressing%20macrophages%20promote%20intestinal%20epithelial%20barrier%20regeneration%20upon%20inflammation&offset=0&pcAvailability=true
Publisher
GUT
Location
영국
Language
영어
ISSN
0017-5749
Citation Volume
70
Citation Number
12
Citation Start Page
2249
Citation End Page
2260
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.